Skip links

Author: oncologs.com

Comprehensive atlas of normal breast cells offers new tool for understanding breast cancer origin

INDIANAPOLIS — Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have completed the most extensive mapping of healthy breast cells to date. These findings offer an important tool for researchers at IU and beyond to understand how breast cancer develops and the differences in breast tissue among genetic ancestries. Credit: Photo courtesy

Fallopian tubes can be safely removed during sterilization

Women whose Fallopian tubes are removed during sterilization via laparoscopy have only marginally more surgical complications than those whose tubes are simply cut, a study shows. The removal, salpingectomy, is a safe procedure that can help protect against future ovarian cancer. Credit: Photo by University

Engineered exosome-based drug delivery system for synergistic cancer therapy

Ovarian cancer is one of the most common malignancies in women worldwide. Unlike breast cancer, ovarian cancer lacks early diagnostic markers and does not show noticeable symptoms until cancer metastases, leading to a low survival rate for ovarian cancer patients. Traditional cancer treatments include surgery,

MD Anderson recognizes outstanding faculty

HOUSTON ― The University of Texas MD Anderson Cancer Center last night recognized over 100 faculty members at its annual Celebration of Faculty Excellence awards ceremony, acknowledging their compassionate care, exceptional contributions to their fields and the distinction they have brought to the institution.  Credit:

Retrotransposon DNA zip code for myeloma cell internalization

“GT is a fascinating evolutionary phenomenon observed in lower species and humans, albeit with differing impacts and mechanisms.” Credit: 2024 Puvvula et al. “GT is a fascinating evolutionary phenomenon observed in lower species and humans, albeit with differing impacts and mechanisms.” BUFFALO, NY- August 9,

The heightened importance of EZH2 in cancer immunotherapy

Enhancer of zeste homolog 2 (EZH2) is a catalytic subunit of the Polycomb-repressive complex 2 (PRC2), which plays a crucial role in transcriptional repression through the methylation of histone H3 on lysine 27 (H3K27me3). This epigenetic modification leads to chromatin compaction and gene silencing. EZH2

Abbruscato, Kang receive first Stocco Research Chair endowment appointments

In a July 9 ceremony, Thomas Abbruscato, Ph.D., and Min Kang, Pharm.D., became the first recipients of the Douglas Stocco Research Chair, an endowment formerly known as the Texas Tech University Health Sciences Center’s (TTUHSC) Research Endowment. The Texas Tech University System Board of Regents

Potential new approach to enhancing stem-cell transplants

August 8, 2024—(BRONX NY)—A discovery by a three-member Albert Einstein College of Medicine research team may boost the effectiveness of stem-cell transplants, commonly used for patients with cancer, blood disorders, or autoimmune diseases caused by defective stem cells, which produce all the body’s different blood
Explore
Drag